716 related articles for article (PubMed ID: 17253469)
1. Allergen injection immunotherapy for seasonal allergic rhinitis.
Calderon MA; Alves B; Jacobson M; Hurwitz B; Sheikh A; Durham S
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001936. PubMed ID: 17253469
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy for allergic rhinitis.
Radulovic S; Calderon MA; Wilson D; Durham S
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002893. PubMed ID: 21154351
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy for treating allergic conjunctivitis.
Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham S
Cochrane Database Syst Rev; 2011 Jul; (7):CD007685. PubMed ID: 21735416
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
7. Specific allergen immunotherapy for the treatment of atopic eczema.
Tam H; Calderon MA; Manikam L; Nankervis H; García Núñez I; Williams HC; Durham S; Boyle RJ
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008774. PubMed ID: 26871981
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy for asthma.
Fortescue R; Kew KM; Leung MST
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
[TBL] [Abstract][Full Text] [Related]
9. Systematic reviews of sublingual immunotherapy (SLIT).
Radulovic S; Wilson D; Calderon M; Durham S
Allergy; 2011 Jun; 66(6):740-52. PubMed ID: 21443635
[TBL] [Abstract][Full Text] [Related]
10. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
[TBL] [Abstract][Full Text] [Related]
11. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
[TBL] [Abstract][Full Text] [Related]
12. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
13. Helminth therapy (worms) for allergic rhinitis.
Croft AM; Bager P; Kumar S
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD009238. PubMed ID: 22513973
[TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
[TBL] [Abstract][Full Text] [Related]
15. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension.
Worm M; Rak S; Samoliński B; Antila J; Höiby AS; Kruse B; Lipiec A; Rudert M; Valovirta E
Clin Exp Allergy; 2019 Apr; 49(4):516-525. PubMed ID: 30570787
[TBL] [Abstract][Full Text] [Related]
17. Intradermal grass pollen immunotherapy increases T
Slovick A; Douiri A; Muir R; Guerra A; Tsioulos K; Hay E; Lam EPS; Kelly J; Peacock JL; Ying S; Shamji MH; Cousins DJ; Durham SR; Till SJ
J Allergy Clin Immunol; 2017 Jun; 139(6):1830-1839.e13. PubMed ID: 27773851
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
20. [Allergen-specific immune therapy in the treatment of asthma].
Malling HJ
Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]